Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Mascia

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Genes|December 23, 2022
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis SusceptibilityFederica Esposito, Ana Maria Osiceanu, Melissa Sorosina, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Acta Neuropathologica|February 4, 2026
A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosisAntonino Giordano, Pernilla Stridh, Paolo Preziosa, et al.
Plos Genetics|June 7, 2019
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of diseaseCarles Vilariño-Güell, Alexander Zimprich, Filippo Martinelli-Boneschi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Genes|December 23, 2022
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis SusceptibilityFederica Esposito, Ana Maria Osiceanu, Melissa Sorosina, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Acta Neuropathologica|February 4, 2026
A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosisAntonino Giordano, Pernilla Stridh, Paolo Preziosa, et al.
Plos Genetics|June 7, 2019
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of diseaseCarles Vilariño-Güell, Alexander Zimprich, Filippo Martinelli-Boneschi, et al.
Pageof 3